http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022047815-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cba2d877e1cacd2cec3d2e95aa93d8a1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_51a2fb589c912853917579f0de0cbc39
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-507
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2827
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2818
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-737
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-737
filingDate 2020-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e499af98f955b36e7c24ae1b9ec52aab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f26ab4a2957adeee727e250c89a80860
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7e26b39f9c16d72d20755bdf33b1a1e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_872f90f375200fe81fb7eeabcf45f966
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98208cd72a4a614ac4adf3991950cbd7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f1c17d61b2ad4e28a88dc50c85255e5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e611dd7aa0c4804c34611007ce234d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8cd2e8b8e1cc48da53829b683178d844
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a82d75dd09db42374d4f0c0e372fbda9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_960d785f0169370e6f33c751837a596f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d0922eba786679c1e33dcc60b37b979
publicationDate 2022-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2022047815-A1
titleOfInvention Pharmaceutical composition for anti-tumor immunotherapy
abstract Use of fucoidan in synergistic enhanced anti-tumor immunotherapy. The combination of the fucoidan and an anti-tumor immunotherapeutic agent antibody can significantly inhibit the growth of a variety of malignant tumors, and obviously enhance the anti-tumor immunotherapeutic effect of the anti-tumor immunotherapeutic agent, proving that the fucoidan can be used as a functional component to prepare drugs or medical foods for use in combination with anti-tumor immunotherapy.
priorityDate 2020-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108785668-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019075449-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467159479
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468122693

Total number of triples: 37.